Oura agrees to acquire Counsel Health for $625 million | Magica
Oura agrees to buy Counsel Health for $625 million, taking ownership of its care partner
Editorial Team
••📖7 min read
The cash deal would bring Oura’s existing AI and physician care partner under its ownership. The $159 annual integration already connects members to doctors, but geographic limits, extra service costs and unproven clinical benefits qualify the expansion.
Oura has agreed to buy its existing care partner, Counsel Health, for $625 million in cash.
Counsel brings a physician-supervised AI platform and enterprise relationships beyond Oura’s ring users.
The existing $159 annual care plan has geographic and cost limits; company satisfaction figures do not establish better clinical outcomes.
Oura, the smart ring and health data company, has agreed to acquire Counsel Health, a primary care company combining medical AI with in-house physicians, for $625 million in cash. The deal would give Oura ownership of a service already integrated into its app, along with a route to patients through health plans, health systems and employers.
The purchase is subject to price adjustments and is expected to close before the end of 2026, subject to customary closing conditions, according to the companies’ transaction announcement.
The strategic change is control of clinical infrastructure and enterprise distribution. Access to doctors through the app predates the agreement, and Oura already receives part of the existing care subscription fee. Ownership would deepen that business, while leaving the companies to demonstrate whether continuous wearable data improves care and its economics.
Founded in Finland in 2013, Oura built a platform around a ring that measures physiological signals and an app that interprets them across sleep, activity, stress and other health indicators. It says it now has more than six million members. Its transaction announcement specifies that Oura Ring is not a medical device and is not intended to diagnose or treat medical conditions.
Counsel was built by physicians and AI researchers. In its October 2025 platform and financing announcement, it said its physician-led medical group was licensed in all 50 states and that it served more than 100,000 members nationwide through partnerships. That is a dated measure of Counsel’s reach, rather than a current acquisition-date patient count.
Alibaba’s Qwen4-Max preview gives developers a fixed model to test through November 25. API access requires Token Plan, while claimed coding gains remain unquantified in the launch materials.
The acquisition announcement describes specialized AI agents that gather medical histories, retrieve guidelines, review records and detect emergencies. Counsel’s physicians provide feedback on their performance. Patients can add a physician to the conversation for diagnosis, prescriptions or referrals when appropriate; the clinician interface assembles medical records and health trends to support decisions.
The companies plan to combine that infrastructure with Oura’s continuous biometric data across preventive, acute, specialty and chronic care, including reproductive, aging and cardiometabolic health. Counsel will continue serving existing and new enterprise partners after the purchase, they say. Reaching millions of patients beyond Oura is an ambition, not a disclosed current result.
Oura advertises a 30-day medical AI trial followed by an optional $159 annual care plan. Additional service costs and geographic limits apply. Graphic: Magica; source: Oura. Source: Oura partnership announcement.
An existing $159 plan with limits
Oura says the partnership began in May 2026. Its partnership page, published June 8 and updated October 19, already advertises a 30-day medical AI trial followed by a $159 annual plan for unlimited medical AI and board-certified doctor access in the app.
The disclosures make the economics more specific. Of the annual fee, $76.50 goes to Counsel Medical Group for physician visits; the rest covers Oura’s administrative costs for operating the platform. Care is provided by the medical group’s licensed physicians. The arrangement therefore already gives Oura a financial role in distributing care.
Physician visits require no insurance or co-pays, but treatment, prescriptions, labs and other services may cost extra. The optional subscription renews annually until canceled. The page lists the experience as unavailable in Arkansas, Kansas, Mississippi, New Mexico, Rhode Island, Washington, West Virginia and the District of Columbia. A medical group’s nationwide licensing does not mean this particular integration is available everywhere.
Oura says data sharing requires permission. More than half of Counsel users in Oura Labs, its experimental environment, have shared their Oura data with physicians since the partnership began, according to its acquisition announcement. That denominator is integration users, not all Oura members. The partnership disclosures also say visit summaries, diagnoses and treatment plans can flow back to Oura if patients direct Counsel to disclose them. The service is not intended for emergencies, and its AI guidance does not replace clinical judgment.
Connecting wearable data to clinical services is already a competitive field. Wearable health platform WHOOP describes Advanced Labs as combining clinician-reviewed blood tests covering 65 biomarkers with continuous wearable data and personalized recommendations. It identifies Quest Diagnostics and SteadyMD as the providers of lab testing and clinical advice, and says its coaching and Action Plan are not medical advice. That offers an alternative route from tracking to clinical testing, with a narrower scope than Counsel’s primary care model.
Company-reported revenue growth was 92 percent for fiscal 2026 and 153 percent for its fourth quarter. Figures are preliminary and unaudited. Graphic: Magica; source: Oura’s announcement published by Counsel Health. Source: Counsel Health.
A cash commitment backed by rapid sales growth
Oura’s preliminary, unaudited financial figures put fiscal 2026 revenue at approximately $1.75 billion, up 92% from a year earlier. The $625 million purchase price is roughly 36% of that annual revenue. This compares the commitment with Oura’s sales scale; it is not a valuation multiple for Counsel or a measure of available cash.
For the quarter ended Sept. 30, Oura reported $533 million in revenue, up 153% year over year, and $87 million in adjusted EBITDA, a reported margin of 16%. Those figures may change after the year-end close and audit. Adjusted EBITDA does not establish how much cash Oura has to fund the acquisition.
The agreement follows Oura’s delay of public offering plans over market uncertainty just over a month earlier, as described in contemporaneous reporting.
Counsel’s October 2025 announcement disclosed a $25 million Series A led by venture investors Andreessen Horowitz and GV, following an $11 million seed round led by Andreessen Horowitz in October 2024. The company said the new funding would expand its physician network, AI investment and enterprise partnerships. Oura is acquiring an operating care business with prior institutional backing, but the acquisition disclosures provide neither Counsel’s revenue nor profitability. Prior fundraising alone cannot establish the return to investors or justify the purchase price.
Oura says the deal would increase customer lifetime value and expand its addressable market through Counsel’s enterprise partners. Those are expected commercial benefits. The disclosures do not establish how physician capacity, utilization or costs would change as the service grows.
What must be demonstrated after closing
The immediate milestone is completing the transaction. The harder test is whether the combination delivers measurable clinical benefits at a sustainable cost while expanding access beyond the existing integration.
The companies’ acquisition announcement says more than 90% of surveyed Counsel users believed their Oura data helped them get better care, and users who saw a Counsel physician rated the experience 4.6 out of 5. It supplies neither a survey sample size nor a clinical comparison group. Reported satisfaction is useful evidence of experience, but it does not demonstrate improved health outcomes.
Counsel’s 2025 financing announcement separately claimed a 96% issue resolution rate, two-minute physician response times and $381 in annual savings per engaged member. It did not disclose the methods or comparison basis needed to independently assess those figures. They should not be treated as demonstrated results of the later Oura integration.
The next consequential disclosures are how access and pricing change, how physician coverage scales, and whether measured outcomes and costs improve against a defined alternative. Those results would show whether bringing care delivery under Oura’s ownership adds value beyond the partnership it already had.
Railway estimates stolen customer keys generated about $740,000 in unauthorized AI spending after an October intrusion. Secrets from up to about 100,000 workspaces could have been decrypted, and the company says it will cover losses providers decline to refund.
Anthropic expects retail investors worldwide to receive up to 20% of its IPO, potentially $12.9 billion at the proposed upper price. Access through six brokerage channels depends on demand and broker rules, while a separate technology-company investment would help finance vast infrastructure commitments and founders and a special trust retain control.
Anthropic's seven founders plan equal IPO share sales worth about $250 million each at the proposed midpoint. Their sales make up 2.9% of the public offering, while the company seeks much larger financing under a structure that limits public investors' voting influence.
Nvidia’s independent directors retained Wachtell Lipton partner Joon H. Kim for an investigation into reports of a foreign intelligence effort targeting co-founder and CEO Jensen Huang. The board previously expressed confidence in Huang; the appointment provides no findings or timetable.
RRE Ventures led the funding for Graphon’s enterprise memory infrastructure. The startup is pitching connected, persistent context across different agents, but benchmark gains leave deployment costs and commercial scale unresolved.
Goldman Sachs, a lead bank on Anthropic’s IPO, reportedly forecasts $685 billion in annual revenue by 2030. The Claude developer has substantial cash reserves and rapidly growing sales, but rising compute costs, competitive pricing and delivery risks complicate the enterprise growth case.
Memories Upload pays contributors for accepted first-person video and sells annotated data to robotics developers. Its million-hour collection claim leaves open how much footage improves robot performance, while contributors surrender ownership without royalties.
OpenAI has acquired AI travel concierge Odessia and is bringing its founder, former Sonder chief Francis Davidson, into its travel effort. The standalone service has closed, leaving its future role alongside ChatGPT’s existing travel partners unclear.
Anthropic says expected advances from future models have triggered its research-acceleration threshold. An outside assessment finds faster progress but does not certify compliance with that threshold, while the voluntary policy leaves consequential decisions about safeguards and continued development with the company.
OpenAI’s free business-profile beta adds branded agents for eligible U.S. ecommerce and online service firms. The agents can also serve as paid-ad destinations, while OpenAI controls distribution and businesses bear responsibility for outputs.
Teleport has made Beams generally available with task-specific infrastructure permissions and a kill switch. Its access-security platform supplies an enterprise foothold, but established competitors and custom pricing for key controls complicate the buying decision.
New York will connect more than 80 researchers with Empire AI computing resources to evaluate advanced AI systems and advise state oversight, expanding a center first announced in January.
Anthropic’s amended IPO filing raises its Microsoft spending commitment while disclosing an exit right from a $34.9 billion Lambda agreement. Google’s larger commitment was already disclosed earlier, and expensive short-term computing continues to squeeze margins.
Reddit is testing AI-organized review pages for roughly 10,000 products. The pages link back to users’ conversations, but lack purchase verification—a safeguard Amazon says it uses for its own AI review highlights.
The renamed MegaETH Foundation is funding its own products after an earlier shift away from its accelerator. Its December inference market must show how it improves on existing services that already route requests by price and reliability.
Cambridge startup Tendrils Compute has raised a Benchmark-led seed round to build processors based on interaction nets. Its backers see an opening in branching workloads, including AI agents, but theoretical parallelism has yet to establish a commercial hardware advantage.
Google and Artificial Analysis launched a 200-task test of AI agents working with visually dense professional files. Google's study finds close leading scores and sharply different API bills, as its new Carbon model reaches customers alongside the Argon alternative.
Google is widening paid access to Gemini 4 Carbon for complex coding, business and scientific work. Gemini API token rates double after November 30, while benchmark results show that its cost advantage depends on the task and reasoning setting.
MiniMax has released downloadable weights for H3-Image, a model combining image generation and editing at native 16-megapixel resolution. Local deployment offers an alternative to its paid API, but hardware demands and a restrictive community license qualify the promise of open access.
